HistoSonics’ phased commercial rollout of the Edison system will initially target centers specializing in liver tumor treatment.
Source: MedTech Dive
You may also like
Knee Pain? Ragged Cartilage? Research Suggests...
Lawmakers Look To Make Abortion Shield Laws Less...
Hospital M&A sustains momentum in Q2: report
Whoop tests wearable platform in joint replacement...
CVS Caremark reaches settlement with FTC over insulin...
HCA cuts 2026 earnings forecast on insurance coverage...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.